The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Size Is Forecasted For The Losartan Potassium Active Pharmaceutical Ingredient (API) Market By 2030 Based On Its 2026 Value?
The market size for losartan potassium active pharmaceutical ingredient (API) has demonstrated robust growth over recent years. This market is projected to expand from $1.85 billion in 2025 to $1.97 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.5%. Historically, this expansion has been driven by factors such as the increasing prevalence of hypertension, the expiry of branded drug patents, the expansion of generic pharmaceutical manufacturing, a heightened demand for cardiovascular medications, and the broadening of global pharmaceutical supply chains.
The losartan potassium active pharmaceutical ingredient (api) market size is anticipated to experience robust expansion in the coming years. It is projected to increase to $2.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This growth during the forecast period is fueled by an increasing burden of cardiovascular diseases, rising demand from emerging markets, innovations in API manufacturing technologies, a growing emphasis on sustainable pharmaceutical production, and the broadening of chronic kidney disease treatment applications. Major trends expected in this period encompass a greater demand for generic losartan formulations, the increasing adoption of continuous flow API manufacturing, a heightened focus on cost-effective antihypertensive APIs, the expanded use of losartan API in combination therapies, and a stronger emphasis on producing regulatory-compliant APIs.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24285&type=smp
What Major Growth Factors Are Impacting The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
The increasing occurrence of hypertension is anticipated to fuel the expansion of the losartan potassium active pharmaceutical ingredient (API) market in the future. Hypertension is defined as a state of consistently elevated blood pressure, which elevates the risk of cardiac conditions, strokes, and other serious health issues. The rising frequency of hypertension is associated with diets high in sodium and processed items, contributing to fluid accumulation and greater stress on the heart. Losartan potassium assists in managing hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This substance aids in relaxing and expanding the vessels, thereby reducing blood pressure and alleviating the heart’s effort. For example, data from September 2025, provided by the World Health Organization (WHO), a global health authority based in Geneva, Switzerland, indicates that around 1.4 billion adults aged 30–79 years suffered from hypertension in 2024, an increase from approximately 1.3 billion adults in 2022. Consequently, the expanding prevalence of hypertension is propelling the growth of the losartan potassium active pharmaceutical ingredient (API) market.
How Does Segment Analysis Break Down The Losartan Potassium Active Pharmaceutical Ingredient (API) Market Structure?
The losartan potassium active pharmaceutical ingredient (api) market covered in this report is segmented –
1) By Product Type: Tablet, Capsule, Other Product Types
2) By Production Method: Synthetic Route, Continuous Flow Production
3) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
4) By Application: Hypertension, Heart Failure, Chronic Kidney Diseases, Other Applications
5) By End-User: Hospitals, Clinics, Pharmaceutical Companies
Subsegments:
1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets, Film-Coated Tablets, Orally Disintegrating Tablets
2) By Capsule: Hard Gelatin Capsules, Modified-Release Capsules
3) By Other Product Types: Bulk Active Pharmaceutical Ingredient (API) Powder, Granules For Suspension, Pre-Formulated Intermediates
What Trends Are Influencing The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
Leading companies within the losartan potassium active pharmaceutical ingredient (API) market are concentrating on creating novel products and securing necessary approvals, including losartan potassium oral suspension, with the aim of improving patient adherence and broadening therapeutic uses. This losartan potassium oral suspension represents a liquid pharmaceutical formulation of losartan potassium, designed for patients experiencing difficulty in swallowing traditional tablets. An example illustrating this trend occurred in March 2025, when Scienture Holdings Inc., a biopharmaceutical firm based in the US, obtained Food and Drug Administration (FDA) approval for its product, Arbli. Arbli is presented as a convenient, ready-to-use liquid formulation indicated for treating hypertension, reducing the risk of stroke in hypertensive individuals with left ventricular hypertrophy, and managing diabetic nephropathy in type 2 diabetes patients. This product ensures accurate dosing without requiring compounding and is supplied as a 165 mL peppermint-flavored suspension (10 mg/mL), maintaining an 18-month shelf life when stored at room temperature.
Who Are The Prominent Players Across The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
Major companies operating in the losartan potassium active pharmaceutical ingredient (api) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy’s Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP
Access The Complete Losartan Potassium Active Pharmaceutical Ingredient (API) Market Report:
What Is The Largest Regional Market In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
North America was the largest region in the losartan potassium API market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan potassium active pharmaceutical ingredient (api) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Losartan Potassium Active Pharmaceutical Ingredient (API) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24285&type=smp
Browse Through More Reports Similar to the Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market 2026, By The Business Research Company
Active Pharmaceutical Ingredients Market Report 2026
Pharmaceuticals Market 2026
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model